The Global Drug Facility is the Stop TB Partnership's procurement and supply mechanism for tuberculosis diagnostics and treatment, created in 2001. It has grown into a one-stop bundled procurement service combining strategic purchasing of TB products and coordination of the market for them with technical assistance and capacity-building for national tuberculosis programmes. New treatments are added to its catalogue soon after approval, as with pretomanid, part of the shorter, all-oral drug-resistant TB regimens recommended by the World Health Organization, which the facility listed within a year of the drug's 2019 approval.
Facts
Connections
Associated With
Source pmc.ncbi.nlm.nih.gov: a unique, holistic and pioneering approach to drug procurement and management
Delivers Practice
Source pmc.ncbi.nlm.nih.gov: a unique, holistic and pioneering approach to drug procurement and management
Sources
1. pmc.ncbi.nlm.nih.gov: a unique, holistic and pioneering approach to drug procurement and management
pmc.ncbi.nlm.nih.govPage text
The Global Drug Facility (GDF) for tuberculosis (TB) was launched on World TB Day 2001; it grew out of a declaration made a year earlier by countries attending the Ministerial Conference on TB and Sustainable Development in Amsterdam.
Delivers Practice: Disease Surveillance, Page text, program-kind-practice
While the kits do not represent a new tool for diagnosing TB, they are expected to serve as an effective interim measure to improve case finding until rapid diagnostic tools are available.
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.